SU011248

What SU011248 Means in Everyday Medical Language

SU011248 is a drug used to treat certain types of cancer. It is also known by other names such as SU11248, sunitinib malate, and the brand name Sutent. This medicine belongs to a group called tyrosine kinase inhibitors and antiangiogenesis agents. It works by blocking proteins that help cancer cells grow and by preventing tumors from making new blood vessels they need to survive and grow.

Why SU011248 Can Matter in Cancer Care

SU011248 is important because it offers a treatment option for adults with specific cancers, including gastrointestinal stromal tumors (GIST), pancreatic neuroendocrine tumors, and renal cell carcinoma (a type of kidney cancer). It may be used when cancer is advanced or has returned after surgery, such as after a kidney removal (nephrectomy). By targeting cancer growth and blood supply, it can help control the disease. Researchers are also studying SU011248 for other cancers to see if it might help more patients in the future.

What Patients Might See or Hear About SU011248

Patients and caregivers might come across the term SU011248 in medical reports, treatment plans, or discussions with their healthcare team. It may also appear in information about clinical trials or drug guides. Because the drug has several names—SU011248, SU11248, sunitinib malate, and Sutent—it can be confusing. The key is to understand that these names refer to the same medicine. If you see this term, it’s a good idea to ask your care team how it relates to your treatment or condition.

Where the Term SU011248 Might Appear

You might find SU011248 mentioned in your medical records, especially in pathology reports, treatment plans, or notes from your doctor. It can also appear on clinical trial websites or drug information pages. Sometimes, it is listed under different names, so comparing the wording can help avoid confusion.

What SU011248 Does Not Automatically Mean

Seeing the term SU011248 does not mean you have a specific diagnosis or that this drug is definitely part of your treatment. It is simply the name of a medicine that may be used for certain cancers. The presence of this term in your records should prompt a conversation with your healthcare team to understand its role in your care.

Common Confusions and How to Avoid Them

Because SU011248 has several names, patients and caregivers might be unsure if they refer to different drugs or treatments. Remember that SU011248, SU11248, sunitinib malate, and Sutent all mean the same medicine. Always ask your care team to clarify what the term means in your specific case to avoid misunderstandings.

Questions to Ask Your Care Team

If you see SU011248 mentioned, consider asking: What is this drug, and how does it relate to my cancer? Is it part of my current or future treatment plan? What are the possible benefits and side effects? Are there clinical trials involving this drug that I might consider? Understanding these points can help you feel more informed and involved in your care.

Reading SU011248 in Context

It’s important to read the term SU011248 within the full context of your medical information. Alone, it is just a drug name and does not provide a diagnosis or treatment decision. Always discuss with your healthcare provider what it means for your health and treatment options.

Safety and Educational Purpose

This information is meant to educate and support patients and caregivers. It does not replace medical advice or decisions made by your healthcare team. Every patient’s situation is unique, so always rely on your doctors and nurses for guidance tailored to your needs.

Next Steps for Patients and Caregivers

If you encounter the term SU011248, the best next step is to ask your care team to explain what it means for you personally. They can provide details about whether this drug is part of your treatment, what to expect, and how it fits into your overall care plan. Staying informed and asking questions helps you take an active role in your cancer journey.